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ABSTRACT 
Objective: To evaluate the effectiveness of Linaria ramosissima (Wall.)Janch as an antidiabetic agent in streptozotocin induced diabetic rats. 
Methods: Diabetes was induced in rats by single intra-peritoneal injection of streptozotocin(STZ) 60 mg/kg body weight. Animals with BGL more 
than 200 mg/dl, 48 hrs after STZ injection were considered as diabetic and were used for experiment. Hydroalcoholic extract of Linaria ramosissima 
(Wall.)Janch was administered for 21 
Results: Mean food and water intake in diabetic group of rats increased as compared to normal control group. Administration of test drug 
(200mg/kg & 400mg/kg) significantly reduced water intake without significant reduction in food intake as compared to normal control group. 
Significant decrease in body weight was observed in diabetic group of rats, but administration of extract significantly improved the body weight. 
Elevated BGL observed in diabetic animals was significantly reduced by administration of extract.Blood glucose lowering effect of extract was 
confirmed by results of histopathology of pancreas. 
days. During treatment period daily food and water intake and weekly body weight and BGL were checked in 
each group of rats. Histopathology of pancreas was performed at the end of experiment. 
Conclusion: The results of the studies confirmed the ethanomedicinal use of Linaria ramosissima (Wall.) Janch in treatment of diabetes by reducing 
BGL, improving parameters like food and water intake, body weight and regeneration of the islets of langerhans. 
Keywords: Anti-diabetic, Glibenclamide, Blood glucose, Acute oral toxicity, Histopathology. 
 
INTRODUCTION 
Diabetes is the most important non infective epidemic to hit the 
globe in the present millennium [1]. The American Diabetes 
Association 2011 defines Diabetes Mellitus (DM) as a wide spread 
metabolic disease characterized by hyperglycemia and 
carbohydrate, protein and fat metabolism disturbances [2]. It is 
characterized by hyperglycemia arising as a consequence of a 
relative or absolute deficiency of insulin secretion, resistance to 
insulin action or both [3]. 
Worldwide the prevalence of diabetes mellitus is estimated to be 
2.8% and is set to rise to 4.4% by 2030 [5].
It is a metabolic syndrome characterized 
by hyperglycemia, polyuria and weight loss, inspite of polyphagia, 
glycosuria, ketosis and acidosis [4].  
 According to a projection 
of the International Diabetes Federation (IDF), approximately 366 
million people are living with diabetes and this figure is projected to 
increase to 552 million by the year 2030 [6], with the greatest 
number of cases being expected in China and India [7]. The IDF 
estimates the total number of diabetic subjects to be around 40.9 
million in India and this is further set to rise to 69.9 million by the 
year 2025 [8]. 
Managemnet of hyperglycemia in most patients with Type II DM 
should begin with lifestyle modification (diet and activity). However, 
diet and exercise fail to achieve glycemic control in most patients 
and thus pharmacologic intervention with oral hypoglycemic agents 
is necessary [10].
India has thus been declared by WHO as the “ 
Diabetes capital of the world” [9]. 
Type 2 Diabetes Mellitus patients are usually treated with oral 
medications including Sulfonylureas, Biguanides Alpha-glucosidase 
inhibitors and Thiazoliddinediones [11]. However, many of these oral 
hypoglycemic agents usually produce serious side effects including 
hypoglycemia, drug-resistance, dropsy and weight gain [12]. 
  
Hence despite the presence of various antidiabetic medicines on the 
market, diabetes and related complications continue to be a major 
problem. Traditionally used medicinal plants can provide an 
alternative approach to treat diabetes [13], 
The ethanobotanical reports state that about 800 plants may 
possess antidiabetic potential [15].
because of their 
effectiveness, less side effects and relatively low cost [14]. 
 
The plant Linaria ramosissima (Wall.)Janch (syn: Kickxia 
ramosissima). belongs to family Scrophulariaceae. It is commonly 
called “kanodi” and “Bhintgalodi” in Gujarati. It is distributed 
throughout India, usually in rocky and stony places, Ceylon and 
Upper Burma [19].
WHO has recommended that 
traditional plant treatments for diabetes warrant further evaluation 
[16], hence over 150 plant extracts and some of their active 
principles, including flavanoids, tannins, alkaloids etc., are used for 
treatment of diabetes [17]. Although several medicinal plants have 
gained importance for the treatment of diabetes mellitus, many 
remain to be scientifically investigated [18].  
 It is also found in the saurashtra region of Gujarat 
[20]. Medicinal properties like Mutrala (diuretic), Rechak 
(purgative), Tikta (bitter), Raktapittahara (blood disorders) have 
been reported [20]. Folk people in saurashtra region use this plant to 
treat urinary stone [20]. 
Hence the present study has been undertaken with the aim to 
evaluate the antidiabetic activity of plant of Linaria ramosissima 
(Wall.) Janch.  
Leaves mixed with black pepper are given 
in fever, Root is used in the management of snake and scorpion bite 
[21]. Traditionally the plant has been reported as an effective 
remedy for diabetes. However literature survey shows no scientific 
evidence regarding antidiabetic activity of the plant. 
MATERIALS AND METHODS 
Plant material and Preparation of extract: 
Whole plant of Linaria ramosissima (Wall.)Janch was collected from 
Gujarat Ayurvedic University, Jamnagar and was identified and 
authenticated by Dr. D.B.Patel, Professor & Head, Department of 
Botany, Bansilal Amrutlal College of Agriculture (B.A.C.A), Anand. 
(Authentification no: BACA/GPB/623/13) A herbarium of whole 
plant was prepared and deposited in Pharmacognosy Deparatment 
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of A.R.College of Pharmacy, Vallabh Vidyanagar (Herbarium no: 
BIP/LR-25/2/ARGH-14 ) 
Plant material was dried in shade at room temperature for 15 days, 
coarsely powdered and the powder was passed through 40# sieve. 
The powdered plant material was subjected to soxhlet extraction 
using water:methanol (30:70) to obtain hydroalcoholic extract. 
Hydroalcoholic extract was evaporated under reduced pressure at low 
temperature (30o
Phytochemical analysis 
C) to dryness to yield a brownish green colour residue. 
(yield- 13.64% w/w) The residue obtained was stored in an airtight 
glass container and was used for evaluation of antidiabetic activity.  
The dried extract was subjected to qualitative analysis for the 
detection of various phytoconstituents present. 
Animals 
Albino rats of wistar strain, weighing 200-300g were procured from 
Zydus Research Centre, Ahmedabad. The animals were housed 
under standard conditions i.e 26 ± 2ºC temp. and relative humidity 
44-56%, maintained on a 12 hr light/dark cycle and had free access 
to food and water. The animals were acclimatized to the laboratory 
environment 1 hr before the experiments. All experiments were 
conducted during the light period (08.00-16.00hrs.). The protocol 
(No: CPCSEA/IAEC/AR CP/13-14/01) of the study was approved by 
the Institutional Animal Ethical Committee (IAEC) and experiments 
were conducted according to the guidelines of CPCSEA (Committee 
for the Purpose of Control and Supervision of Experiments on 
Animals). 
Acute oral toxicity study [22] 
Acute oral toxicity study was performed as per Organization for 
Economic Cooperation and Development (OECD) guidelines 423. 
Drugs 
Stepwise dose of extract of Linaria ramosissima (Wall.)Janch 
(5,50,300 and 2000 mg/kg body weight p.o.),was administered and 
animals were observed individually atleast once during the first 30 
minutes and periodically during the first 24 hrs., with special 
attention given during the first 4 hrs and daily thereafter, for a total 
of 14 days. 
Streptozotocin was purchased from Himedia Chemical, Mumbai, 
India. Glibenclamide was obtained as gift sample from Yarrow Chem 
Products, Mumbai, India. 
Induction of Diabetes [23] 
Diabetes was induced in the overnight fasted rats by a single intra-
peritoneal injection of 60 mg/kg body weight streptozotocin 
dissolved in 0.1 M sodium citrate buffer, pH 4.5. After the injection 
they had free access to food and water. The animals were allowed to 
drink 5% glucose solution overnight to overcome hypoglycaemic 
shock. The development of diabetes was confirmed after 48 hrs of 
streptozotocin injection. The animals having blood glucose level 
more than 200 mg/dl were considered as diabetic and were used for 
the experimentation.  
Experimental procedure 
In experiment total 30 rats were used. The rats were divided into 5 
groups of 6 rats each 
GROUP I: Normal control rats 
GROUP II: Diabetic control rats  
GROUP III: Diabetic rats treated with standard drug (Glibenclamide 
10 mg/kg b.wt, po) 
GROUP IV: Diabetic rats treated with plant extract (200mg/kg b.wt, 
po) 
GROUP V: Diabetic rats treated with plant extract (400mg/kg b.wt, 
po) 
All drug treatment was given for 21 days. During treatment period 
daily food & water intake of rats in each group was checked. Body 
weight of rats of all groups was checked at weekly interval. Blood 
sample was collected from retro orbital plexus on day 0 and on 7th, 
14th and 21st day after drug treatment to estimate blood glucose 
level. On the last day of experiment (21st
Statistical Analysis 
 day of drug treatment) 3 
rats from each treatment group were sacrificed & specimens of 
pancreas were obtained for histopathological studies.  
All the results were tested for significance using One-Way ANOVA 
followed by Tukey’s test and the results were expressed as mean ± 
S.E.M. at the probability level of 95%. 
RESULTS 
Phytochemical analysis 
Preliminary qualitative phytochemical screening showed the 
presence of Carbohydrates, Phytosterol, Cardiac glycosides, 
Saponins, Flavonoids, Alkaloids, Tannins and Phenolic compounds. 
Acute oral toxicity study 
The acute oral toxicity study showed that hydroalcoholic extract of 
Linaria ramosissima (Wall.)Janch was devoid of any toxicity even at 
the dose of 2000 mg/kg b.wt. Hence 200mg/kg and 400 mg/kg b.wt 
doses were selected for the study. 
Effect of Hydroalcoholic extract of Linaria ramosissima 
(Wall.)Janch on food intake 
Mean food intake in diabetic group of rats increased from 
78.18±8.91 gms in the 1st week to 101.7±3.92 gms (+30%) at the 
end of 3rd week. Treatment with standard antidiabetic drug 
Glibenclamide (10mg/kg) reduced mean food intake from 
101.7±16.8 gms in the 1st week to 79.87±17.32 gms (-21.4%) by the 
end of 3rd week. Similarly both doses of test drug (200mg/kg & 400 
mg/kg) reduced mean food intake from 96.58±6.57 gms amd 
91.45±5.23 gms in the 1st week to 83.28±16.15 gms (-13.75%) and 
64.11±4.59 (-29.89%) gms at the end of 3rd
 
 week respectively. However 
as compared to normal control group the decrease in food intake 




































Fig. 1: Mean food intake per week up to 3 weeks in different 
treatment groups 
 
Effect of Hydroalcoholic extract of Linaria ramosissima 
(Wall.)Janch on water intake 
Water consumed by the different groups of rats was recorded daily 
and mean water intake per week was calculated. Water intake in 
diabetic group of rats increased from 262.6±33.11 ml in the 1st week 
to 273.7±8.41 ml (+4.2%) in the 3rd
The mean water consumption in Glibenclamide treated group of rats 
was 256.1±14.08 ml in the 1
 week. Comparing the water 
intake in diabetic groups with normal control animals the difference 
was found to be highly signifiacant(p<0.001). (Fig-2) 
st week which reduced to 239.9±16.4 ml 
(-6.32%) in the 3rd week. Similarly with both doses of test drug 
(200mg/kg & 400 mg/kg) the mean water consumption reduced 
from 266.3±11.22 ml and 266.9±11.52 ml in the 1st week to 
218.9±18.02 ml (-17.7%) and 24.7±4.84 ml (-15.8%) in the 3rd week 
respectively. Comparing the decrease in mean water intake 
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produced by standard drug Glibenclamide and both doses of test 
drug with normal control (non-diabetic)animals the difference was 
found to be significant(p<0.01). 
However, comparing the decrease in water consumption produced 
by both standard and test drugs with positive control (diabteic) 




































 Fig. 2: Mean water intake per week upto 3 weeks in different 
treatment groups 
 
Effect of Hydroalcoholic extract of Linaria ramosissima 
(Wall.)Janch on Body Weight 
Table 1 shows the effect of hydroalcoholic extract of Linaria 
ramosissima (Wall.)Janch on body weight of the animals.  
As is evident from the table, mean body weight of diabetic control 
animals on 0 day was 220±9.3 gms which reduced to 178±6.0 gms (-
19.%) on 21st day of induction of diabetes. This decrease in body 
weight of diabetic animals was statistically significantly (p<0.001) as 
compared to normal control animals. Administration of 
hydroalcoholic extract of Linaria ramosissima(Wall.)Janch in both 
doses (200mg/kg & 400mg/kg) showed significant (p<0.05) 
improvement in body weight compared to diabetic groups. Mean 
body weight of animals in test group-1 and test group-2 increased 
from 216.7±12.8 gms & 220±9.3 gms on 0 day to 240.8±12.19 gms 
(+11.1%) and 245±7.63 gms (+11.3%) on 21st
Similar results of significant improvement (p<0.01) in body weight 
as compared to diabetic control group of animals were obtained 
with administration of standard antidiabetic drug Glibenclamide (10 
mg/kg), which increased body weight from 228.3±10.14 gms to 
251.7±13.08 gms (+10.2%) at the end of the study (21
 day after induction of 
diabetes respectively. 
st
Tabel 1: Effect of Hydroalcoholic extract of Linaria ramosissima (Wall.)Janch on Body Weight 
 day). 
Groups Mean Body weight (gms) 
 0 day 7 day 14 day 21 day 
Normal control 236.7±7.6 255.0±8.0(+7.7%) 259.2±7.4(+9.5%) 265.0±9.8(11.9%)              








































Values are expressed as mean ± S.E.M., n=6, ***p<0.001,as compared to normal control group **p<0.01, *p<0.05, as compared to positive control 
group by One Way ANOVA followed Tukey’s test 
 
Time dependent effect of Linaria ramosissima (Wall.)Janch on 
blood glucose level (BGL) 
Table 2 shows variation in BGL from 1st day to 21st day in each 
group. Mean BGL in non-diabetic control animals ranged from 
94.33±1.68 mg/dl on 0 day to 98.50±0.99 mg/dl on 21st day of the 
study. In STZ-induced diabetic animals the BGL increased 
significantly (p<0.001) from 447.2±31.32 mg/dl on 0 day to 
530.2±24.22 mg/dl (+18.5%) on day 21st day of the study. With 
standard drug Glibenclamide (10mg/kg) the BGL reduced from 
381.2±52.79 mg/dl on 0 day to 237.8±37.38 mg/dl on 21st day. This 
difference was found to be highly significant(p<0.001) when 
compared with diabetic control group. Test drug in the dose of 200 
mg/kg significantly reduced BGL from 402.8±43.4 mg/dl on 0 day to 
292.7±39.15 mg/dl (-27.3%) on 21st day. 400mg/kg dose of test 
drug also reduced BGL from 470.0±12.65 on 0 day to 305.7±16.56 
mg/dl (-34.9%) on 21st
 
 day, but the difference was not found to be 
significant. 
Table 2: Time dependent effect of Linaria ramosissima (Wall.)Janch on blood glucose level (BGL) 
Groups Day wise Blood Glucose Level (mg/dl) 
 0 day 7 days 14 days 21 days 
Normal control 94.33±1.68 95.33±1.49 97.83±0.87 98.50±0.99 
Positive control 447.2±31.3 494.2±27.2(+10.5%) 512.3±26.2(+14.5%) 530.2±24.2(+18.5%)***  
     
Standard 

































Values are expressed as mean ± S.E.M., n=6, ***p<0.001, as compared to normal control group***p<0.001,**p<0.05,as compared to positive control 
group by One Way ANOVA followed by Tukey’s Test 
 
Effect of Hydroalcoholic extract of Linaria ramosissima 
(Wall.)Janch on pancreas by Histopathology 
Fig 3A shows normal islets of langerhans and β cells in pancreas of 
normal control group.(non-diabetic) In positive control group  
(Diabetic) the number of pancreatic islets as well as β-cells is 
reduced as compared to control group with most of β-cells being 
destroyed. (Fig 3B) Section of pancreas from groups treated with 
glibenclamide (Fig 3C) and both doses of test drug (Fig 3D & 3E) 
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showed increase in pancreatic islets & number of β-cells in the 
pancreas. The damaged β-cell seen after induction of diabetes were 
no longer observed after treatment with extract. This indicates that 
the test drug causes regeneration of β-cell of islets of langerhans of 




Fig. 3a: Normal Control (Non-diabetic) 
 
 
Fig. 3b: Positive Control (Diabetic) 
 
 
Fig. 3c: Glibenclamide Standred drug (10 mg/kg) 
 
 
Fig. 3d: Test-1 (Low dose) 200 mg/kg 
 
Fig. 3e: Test-2 (High dose) 400 mg/kg 
 
DISCUSSION 
Streptozotocin (STZ) is an antibiotic obtained from Streptomyces 
achromogenes. It enters the pancreatic β-cells via a glucose 
transporter-GLUT2 and causes alkylation of deoxyribonucleic acid 
(DNA) [24], 
Usually, the intraperitoneal injection of a single dose of STZ 60 
mg/kg body weight exerts direct toxicity on β-cells resulting in 
necrosis within 48 hrs and causes permanent hyperglycemia [26].
which causes the generation of superoxide, hydrogen 
peroxide, nitric oxide and hydroxyl radicals which are responsible 
for β-cell damage and necrosis resulting in diabetes [25]. 
 
Diabetes is characterized by polyphagia which is evident from the 
increase in food intake observed
STZ was used in the present study for the induction of diabetes in 
rats. 
 
Another characteristic sign of diabetes is polydypsia which is 
evident by increase in water intake in diabetic groups of animals. 
The plant extract decreased the water consumption to near normal 
levels, which were comparable to standard antidiabetic drug 
Glibenclamide. Other scientists have also reported decrease in food 
and water intake by use of herbal antidiabetic drugs [27]. 
in diabetic group of animals. 
However, the food intake in animals treated with extract was less as 
compared to diabetic control group and was comparable with 
standard antidiabetic drug Glibenclamide. 
Deficiency of insulin brings about improper metabolism of 
carbohydrate, lipids and proteins leading to increased 
gluconeogenesis, glycogenolysis, lipolysis and muscle wasting [28]. 
Treatment with the extract showed a significant increase in body 
weight, which may be due to the effectiveness of the drug in 
reversing gluconeogenesis and improving glycemic control and thus 
exert a protective effect in controlling muscle wasting [27].
The phenomenon of muscle wasting occurs due to nonavailability of 
carbohydrate for energy metabolism leading to protein breakdown 
in skeletal muscles and thus causes loss of body weight in diabetic 
animals [29]. 
Similar observations of increase in body weight produced by various 
plant drugs with esthblished antidiabetic activity like Juniperus 
communis(L.) [29], Calotropis procera [30], Garuga pinnata [31],
  
 
Diabetic animals showed increase in BGL which was reduced by 
administration of both doses of extract. The possible mechanism by 
which the extract produced antidiabetic glycemic action in diabetic 
rats may be by potentiating the insulin effect of plasma by increasing 
either the pancreatic secretion of insulin from the existing β-cells or 
by its release from the bound form [34]
Cinnamomum tamala [32] and Momordica tuberose [33] have been 
reported. 
 or by promoting 
regeneration of β-cells or inhibiting endogenous glucose production 
or by inhibition of intestinal glucose absorption [35]. 
It is reported that flavanoids [37],
A pancreatic 
mechanism is possible because in mild diabetes induced by STZ all 
the β-cells of the pancreas are not destroyed. The surviving β cells 
retain the capacity to synthesize and secrete insulin [36]. 
 phytosterols [1], alkaloids [38], 
glycosides [39] and phenolic compounds [40, 41], constitute the 
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active biological principle of most medicinal plants with 
hypoglycemic and antidiabetic properties [42]. Flavonoids are 
reported to regenerate the damaged pancreatic β cells in diabetic 
animals [43]. Polyphenol such as tannins and saponins reduce blood 
glucose level through inhibition of α amylase and sucrase from the 
intestine [44, 45]. Thus the significant antidiabetic activity of the 
extract may be attributed to synergistic effect of such 
phytoconstituents present in the plant. Results of histopathological 
studies show increase in the number of islets and β cells through 
proliferation of residual, pancreatic β cells thus restoring normal 
structural integrity of islets of langerhans [27]. Various 
histopathology studies have demonstrated an effective increase in 
number of β-cells in pancreas of diabetic rats treated with various 
plant extracts like Momordica tuberose [34], Juglans regia L [46] and 
Teucrium polium [47] all of which 
CONCLUSION 
possess antidiabetic activity. 
In conclusion, the findings of present study demonstrated that 
hydroalcoholic extract of Linaria ramosissima (Wall.)Janch possesses 
favourable antidiabetic activity against STZ induced diabetes in 
wistar rats thus confirming the traditional/ethanomedical use of the 
plant in the treatment of diabetes. 
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